Featured video: Researchers discuss queer visibility in academia
In “Scientific InQueery,” LGBTQ+ MIT faculty and graduate students describe finding community and living their authentic lives in the research enterprise.
Department
Biology
Symposium highlights scale of mental health crisis and novel methods of diagnosis and treatment
Co-hosted by the McGovern Institute, MIT Open Learning, and others, the symposium stressed emerging technologies in advancing understanding of mental health and neurological conditions.
Catalyst Symposium helps lower “activation barriers” for rising biology researchers
Second annual assembly, sponsored by the Department of Biology and Picower Institute, invited postdocs from across the country to meet with faculty, present their work to the MIT community, and build relationships.
John Fucillo: Laying foundations for MIT’s Department of Biology
The Building 68 manager’s leadership, innovation, and laid-back attitude have helped to build a strong culture of community.
New technique reveals how gene transcription is coordinated in cells
By capturing short-lived RNA molecules, scientists can map relationships between genes and the regulatory elements that control them.
QS ranks MIT the world’s No. 1 university for 2024-25
Ranking at the top for the 13th year in a row, the Institute also places first in 11 subject areas.
Ten with MIT connections win 2024 Hertz Foundation Fellowships
The fellowships provide five years of funding to doctoral students in applied science, engineering, and mathematics who have “the extraordinary creativity and principled leadership necessary to tackle problems others can’t solve.”
“Rosetta Stone” of cell signaling could expedite precision cancer medicine
An atlas of human protein kinases enables scientists to map cell signaling pathways with unprecedented speed and detail.
Eleven from MIT awarded 2024 Fulbright fellowships
The Fulbright US Student Program funds research, study, and teaching opportunities abroad.
The beauty of biology
Senior Hanjun Lee planned to pursue chemistry at MIT. A course in genetics changed that.
Taking RNAi from interesting science to impactful new treatments
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.
QS World University Rankings rates MIT No. 1 in 11 subjects for 2024
The Institute also ranks second in five subject areas.
3 Questions: Progress on updating MIT’s undergraduate curriculum
Professors Adam Martin and Joel Volman explain the genesis, scope, and objectives of the recently launched Task Force on the MIT Undergraduate Academic Program.
Five MIT faculty members take on Cancer Grand Challenges
Joining three teams backed by a total of $75 million, MIT researchers will tackle some of cancer’s toughest challenges.
Scientists develop a rapid gene-editing screen to find effects of cancer mutations
With the new technique, MIT researchers hope to identify mutations that could be targeted with new cancer therapies.